Research ArticleCardiovascular
Treatment with Standard and Low Dose of Conjugated Equine Estrogen Differentially Modulates Estrogen Receptor Expression and Response to Angiotensin II in Mesenteric Venular Bed of Surgically Postmenopausal Hypertensive Rats
Priscila Xavier Araujo, Tiago Januário Costa, Cinthya Echem, Maria Aparecida de Oliveira, Rosangela Aparecida Santos-Eichler, Lucas Giglio Colli, Francesc Jiménez-Altayó, Elisabet Vila, Eliana Hiromi Akamine, Ana Paula Dantas, Graziela Scalianti Ceravolo and Maria Helena Catelli de Carvalho
Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 98-107; DOI: https://doi.org/10.1124/jpet.117.240465
Priscila Xavier Araujo
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Tiago Januário Costa
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Cinthya Echem
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Maria Aparecida de Oliveira
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Rosangela Aparecida Santos-Eichler
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Lucas Giglio Colli
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Francesc Jiménez-Altayó
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Elisabet Vila
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Eliana Hiromi Akamine
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Ana Paula Dantas
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Graziela Scalianti Ceravolo
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
Maria Helena Catelli de Carvalho
Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d’Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleCardiovascular
Dose-Dependent Regulation of Venular Function by CEE
Priscila Xavier Araujo, Tiago Januário Costa, Cinthya Echem, Maria Aparecida de Oliveira, Rosangela Aparecida Santos-Eichler, Lucas Giglio Colli, Francesc Jiménez-Altayó, Elisabet Vila, Eliana Hiromi Akamine, Ana Paula Dantas, Graziela Scalianti Ceravolo and Maria Helena Catelli de Carvalho
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 98-107; DOI: https://doi.org/10.1124/jpet.117.240465
Research ArticleCardiovascular
Dose-Dependent Regulation of Venular Function by CEE
Priscila Xavier Araujo, Tiago Januário Costa, Cinthya Echem, Maria Aparecida de Oliveira, Rosangela Aparecida Santos-Eichler, Lucas Giglio Colli, Francesc Jiménez-Altayó, Elisabet Vila, Eliana Hiromi Akamine, Ana Paula Dantas, Graziela Scalianti Ceravolo and Maria Helena Catelli de Carvalho
Journal of Pharmacology and Experimental Therapeutics July 1, 2017, 362 (1) 98-107; DOI: https://doi.org/10.1124/jpet.117.240465
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement